The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: a1-antitrypsin, Quantitative, A1AT, Quantitative, AAT, Quantitative, Alpha1 Antitrypsin, Quantitative, Alpha1Antitrypsin Quantitative
Also known as: AFP and AFP-L3%, AlphaFetoprotein AFP and AFPL3
Also known as: Bilirubin Fractionated
Also known as: Copper Oxide, Wilson's Disease
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Also known as: HAV Antibody, HAV Total, Hepatitis A Antibody Total
Also known as: Anti-HBc, IgM, Hepatitis B Core Antibody IgM
Also known as: Australian Antigen, Auszyme, HBsAg
Also known as: Anti HCV, HCV Antibody
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
Also known as: Lactate Dehydrogenase LD, LDH
Also known as: Pro Time with INR, Prothrombin Time and International Normalized Ratio, Prothrombin Time PT with INR, Prothrombin Time with INR, Protime with INR, PT
The LH-3. Liver Health panel contains 14 tests with 42 biomarkers.
Brief Description: The LH-3 Liver Health panel is an extensive diagnostic tool designed to provide a comprehensive assessment of liver health. This panel includes a wide range of tests that evaluate liver function, screen for liver infections, and assess liver damage. It comprises Quantitative Alpha-1-Antitrypsin, Alpha-Fetoprotein and AFP-L3, Fractionated Bilirubin, Ceruloplasmin, Comprehensive Metabolic Panel, Copper, Gamma Glutamyl Transferase, Hepatitis A, B, and C antibodies and antigens, Iron and Total Iron Binding Capacity, Lactate Dehydrogenase, and Prothrombin Time with INR.
Collection Method: Blood draw
Specimen Type: Whole Blood and Serum
Test Preparation: Patient should be fasting for at least 9 hours prior to collection. Specimen collection should be done in the morning.
Healthcare providers may order the LH-3 panel for individuals exhibiting symptoms of liver disease, such as jaundice, abdominal pain, or fatigue. It's also crucial for those with risk factors for liver diseases, including a history of alcohol use, hepatitis virus exposure, or family history of liver disorders. The panel aids in diagnosing various liver conditions, monitoring the progression of liver diseases, and evaluating the effectiveness of liver treatments.
The LH-3 panel is instrumental in diagnosing and managing:
Healthcare professionals use LH-3 panel results to:
For those seeking an even more detailed liver health assessment, the LH-4 Liver Health panel offers additional tests, including Des-Gamma-Carboxy Prothrombin for liver cancer risk assessment and Quantitative Hepatitis C Viral RNA Real-Time PCR for detailed hepatitis C analysis. This panel provides a deeper dive into liver health, particularly useful for high-risk patients or those with complex liver conditions.
The LH-3 Liver Health panel offers a thorough evaluation of liver function, damage, and disease, providing critical insights for diagnosing and managing liver conditions. By assessing a wide range of liver-related markers, healthcare professionals can tailor treatment strategies to individual patient needs, improving outcomes and quality of life for those with liver diseases.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.